{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:33Z","timestamp":1753890513790,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There are different types of transcatheter mitral valve repair (TMVr) currently in clinical use, including leaflet approximation, annular cinching, and restoration of the chordal apparatus of the mitral valve (MV). While the concomitant combination (COMBO) therapy of mitral transcatheter edge-to-edge repair (M-TEER) with another TMVr concept has been proven feasible, potentially offering patient-tailored treatment for severe mitral regurgitation (MR), a comparison with M-TEER alone has not been made.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To evaluate the procedural and clinical outcome of COMBO therapies compared with M-TEER alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included consecutive patients undergoing COMBO and M-TEER between March 2015 and April 2018 at our Heart Valve Center, while excluding patients presenting a case of redo or with previous MV surgery. Procedural outcomes and all-cause mortality were compared between COMBO therapy vs. M-TEER alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 357 patients (mean age 78.9\u2009\u00b1\u20097.0 years, 53.2% male, M-TEER <jats:italic>n<\/jats:italic>\u2009=\u2009322, COMBO <jats:italic>n<\/jats:italic>\u2009=\u200935; COMBO: MitraClip and the Carillon mitral contour system <jats:italic>n<\/jats:italic>\u2009=\u200926, MitraClip and Cardioband <jats:italic>n<\/jats:italic>\u2009=\u20095, and MitraClip and NeoChord <jats:italic>n<\/jats:italic>\u2009=\u20094) were analyzed. Patients with COMBO therapy had larger left chamber sizes, a lower left ventricular systolic ejection fraction (LVEF; COMBO: 37.4\u2009\u00b1\u200913.8%, M-TEER: 47.9\u2009\u00b1\u200914.3%, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001), and a more severe MR grade (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). There were no significant differences in the prevalence of residual MR \u22672+. However, the need for re-intervention, always employing M-TEER, was more common in the COMBO group. During a mean 3.6-year long-term follow-up, there was no significant difference of all-cause mortality between both groups (Log rank <jats:italic>p<\/jats:italic>\u2009=\u20090.921).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>COMBO therapy may still be a beneficial therapy option for patients with severe MR who already have a more dilated left ventricle (LV), a more severe MR, and a more pronounced LV systolic dysfunction. The higher need for re-intervention in the COMBO group may signal more complex anatomies and possibly underlines the necessity of treating significant MR earlier. Future research is required to establish the COMBO approach as a toolbox-like treatment option, thus offering a patient-tailored approach depending on the individual anatomy and pathology.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1223588","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:51:39Z","timestamp":1708923099000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of COMBO therapy for severe mitral regurgitation compared with transcatheter edge-to-edge repair"],"prefix":"10.3389","volume":"11","author":[{"given":"Hiroaki","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias Friedrich","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa Ann Maria","family":"G\u00f6\u00dfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Zirbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben Luca","family":"Schwidtal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"M\u00fcnzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Stephan","family":"von Bardeleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2007.12.005","article-title":"Outcomes in mitral regurgitation due to flail leaflets: a multicenter European study","volume":"1","author":"Grigioni","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamacardio.2017.2976","article-title":"Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis","volume":"2","author":"Sannino","year":"2017","journal-title":"JAMA Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ahj.2012.05.014","article-title":"Anatomy, mechanics, and pathophysiology of the mitral annulus","volume":"164","author":"Silbiger","year":"2012","journal-title":"Am Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jcmg.2018.01.009","article-title":"Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions","volume":"11","author":"El Sabbagh","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","article-title":"Atrial functional mitral regurgitation: JACC review topic of the week","volume":"73","author":"Deferm","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jcmg.2021.02.008","article-title":"Severe atrial functional mitral regurgitation: clinical and echocardiographic characteristics, management and outcomes","volume":"14","author":"Mesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.jcmg.2022.05.009","article-title":"Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation","volume":"15","author":"Doldi","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001564","article-title":"Transcatheter mitral valve repair: an overview of current and future devices","volume":"8","author":"De Backer","year":"2021","journal-title":"Open Heart"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.jacc.2015.10.018","article-title":"Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II","volume":"66","author":"Feldman","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"60","author":"Vahanian","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/j.jcin.2016.06.028","article-title":"Percutaneous direct annuloplasty with Cardioband to treat recurrent mitral regurgitation after MitraClip implantation","volume":"9","author":"Latib","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/eurheartj\/ehx595","article-title":"First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and NeoChord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging","volume":"39","author":"von Bardeleben","year":"2018","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcin.2017.11.007","article-title":"Combined MitraClip edge-to-edge repair with millipede IRIS mitral annuloplasty","volume":"11","author":"Rogers","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1029103","DOI":"10.3389\/fcvm.2023.1029103","article-title":"Reverse cardiac remodeling in patients undergoing combination therapy of transcatheter mitral valve repair","volume":"10","author":"Yokoyama","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","article-title":"Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (endovascular valve edge-to-edge REpair study) cohort","volume":"54","author":"Feldman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.109.849885","article-title":"Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device European union study","volume":"120","author":"Schofer","year":"2009","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jchf.2019.06.011","article-title":"The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation","author":"Witte","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"Y61","DOI":"10.4244\/EIJV12SYA15","article-title":"The Cardioband: strategies for optimal patient selection and optimised results","volume":"12","author":"Maisano","year":"2016","journal-title":"EuroIntervention"},{"key":"B21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jacc.2013.07.090","article-title":"Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT trial (transapical artificial chordae tendinae) proof of concept","volume":"63","author":"Seeburger","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.21037\/acs.2018.11.04","article-title":"Transapical NeoChord mitral valve repair","volume":"7","author":"Colli","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjci\/jer316","article-title":"EAE\/ASE recommendations for image acquisition and display using three-dimensional echocardiography","volume":"13","author":"Lang","year":"2012","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.amjcard.2006.02.056","article-title":"Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation","volume":"98","author":"Kongsaerepong","year":"2006","journal-title":"Am J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","article-title":"Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction","volume":"336","author":"Vasan","year":"1997","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.athoracsur.2007.08.040","article-title":"Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure","volume":"85","author":"Braun","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","article-title":"Five-year follow-up after transcatheter repair of secondary mitral regurgitation","volume":"388","author":"Stone","year":"2023","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ehjci\/jez073","article-title":"MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results","volume":"20","author":"Pibarot","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jchf.2021.03.002","article-title":"Percutaneous mitral valve annuloplasty in patients with secondary mitral regurgitation and severe left ventricular enlargement","volume":"9","author":"Anker","year":"2021","journal-title":"JACC Heart Fail"},{"key":"B33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.119.039612","article-title":"Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure","volume":"140","author":"Packer","year":"2019","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.carrev.2020.02.012","article-title":"Long-term survival following transcatheter mitral valve repair: pooled analysis of prospective trials with the carillon device","volume":"21","author":"Lipiecki","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/eurheartj\/ehy424","article-title":"Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes","volume":"40","author":"Messika-Zeitoun","year":"2019","journal-title":"Eur Heart J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.21037\/acs-2020-mv-86","article-title":"Transapical off-pump echo-guided mitral valve repair with neochordae implantation mid-term outcomes","volume":"10","author":"Gerosa","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1177\/0962280219887196","article-title":"Performance of propensity score matching to estimate causal effects in small samples","volume":"29","author":"Andrillon","year":"2020","journal-title":"Stat Methods Med Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1223588\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T04:51:41Z","timestamp":1708923101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1223588\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2024.1223588"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1223588","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"article-number":"1223588"}}